Pear Therapeutics עובדים 2024

מה עושה Pear Therapeutics?

Pear Therapeutics Inc was founded in 2013 by Corey McCann and is headquartered in Boston, Massachusetts. The company aims to transform healthcare for millions of people by developing innovative digital therapeutics. Pear Therapeutics' business model focuses on developing digital therapeutics that are approved by regulatory agencies such as the US Food and Drug Administration (FDA) to help patients with disorders such as addiction, sleep disorders, and chronic pain. Pear Therapeutics operates in the healthcare and pharmaceutical industries. It collaborates with major pharmaceutical companies and health organizations that are committed to improving patient care. The company has developed several groundbreaking digital therapies for conditions such as alcohol addiction, tobacco dependency, opioid addiction, sleep disorders, and impatience, which help patients manage their symptoms and improve their lives. One of Pear Therapeutics' key products is the digital therapeutic called ReSet. ReSet is a smartphone app that uses individual behavioral treatment based on cognitive behavioral therapy, motivational interviews, and other behavior change techniques to help patients manage their addiction. The app also uses a biofeedback system that provides the patient with feedback on their condition and encourages them to change their habits. Another important digital therapy from Pear Therapeutics is Somryst, an app focused on treating insomnia and other sleep-related disorders. Somryst is based on cognitive behavioral therapy for insomnia (CBTI), which is considered the most effective non-medication treatment for sleep disorders. The app also uses artificial intelligence to track the patient's condition and develop personalized therapies. Pear Therapeutics has also conducted regular clinical trials to evaluate the effectiveness of its digital therapeutics. A clinical trial conducted in 2018 found that patients who used ReSet showed significant improvements in alcohol abstinence rates compared to a control group. Another study from 2020 showed that Somryst patients had significantly higher sleep quality and longer sleep times compared to the control group. Through its groundbreaking technologies, Pear Therapeutics has the potential to revolutionize the digital medicine market and change the way people use medical therapies. The company has won several awards and grants in the past, highlighting its importance in the industry. Pear Therapeutics also plays an important role in promoting digitization in healthcare. The company has advanced initiatives to improve healthcare in rural areas and integrate digital therapeutics into regular medical care. It is also working on developing partnerships with hospitals and medical facilities to improve patient care and have a positive impact. Pear Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.